Loading...
XNYS
TFX
Market cap5.33bUSD
Dec 05, Last price  
120.50USD
1D
1.38%
1Q
-7.80%
Jan 2017
-25.22%
Name

Teleflex Inc

Chart & Performance

D1W1MN
XNYS:TFX chart
P/E
76.43
P/S
1.75
EPS
1.58
Div Yield, %
0.85%
Shrs. gr., 5y
Rev. gr., 5y
3.26%
Revenues
3.05b
+2.45%
2,514,552,0002,646,757,0001,934,332,0002,420,949,0001,890,062,0001,801,705,0001,528,911,0001,551,009,0001,696,271,0001,839,832,0001,809,690,0001,868,027,0002,146,303,0002,448,383,0002,595,362,0002,537,156,0002,809,563,0002,791,041,0002,974,489,0003,047,324,000
Net income
70m
-80.45%
138,817,000139,430,000146,484,000119,774,000302,994,000201,094,000323,329,000-190,057,000150,881,000187,679,000244,863,000237,377,000152,530,000200,802,000461,466,000335,324,000485,374,000363,139,000356,328,00069,675,000
CFO
636m
+24.50%
335,892,000344,662,000393,588,000171,169,000204,171,000213,102,00094,478,000186,054,000226,544,000286,565,000300,810,000408,480,000419,885,000437,378,000439,525,000436,406,000651,419,000342,141,000510,638,000635,739,000
Dividend
Aug 15, 20240.34 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
IPO date
Mar 17, 1980
Employees
15,500
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT